Literature DB >> 14067227

EXPERIMENTAL ASCITES. III. PRODUCTION OF ASCITES BY DIRECT LIGATION OF HEPATIC VEINS.

M J ORLOFF, M H WALL, E B HICKMAN, B R SPITZ.   

Abstract

Keywords:  ASCITES; DOGS; EXPERIMENTAL LAB STUDY; HEPATIC VEINS; HYPERTENSION, PORTAL

Mesh：

Year:  1963        PMID： 14067227

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  7 in total

1.  EXPERIMENTAL ASCITES. V. PRODUCTION OF HEPATIC OUTFLOW BLOCK AND ASCITES WITH A HEPATIC VEIN CHOKER.

Authors:  M J ORLOFF; R M BADDELEY; T H ROSS; R O NUTTING; H S THOMAS; N A HALASZ; R D SLOOP
Journal:  Ann Surg       Date:  1965-02       Impact factor: 12.969

2.  Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension.

Authors:  C L Witte; M H Witte; A E Dumont; J Frist; W R Cole
Journal:  Ann Surg       Date:  1968-10       Impact factor: 12.969

3.  Major hepatic vein ligation necessitated by blunt abdominal trauma.

Authors:  D J Depinto; S J Mucha; P C Powers
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

4.  Effect of portacaval shunt on gastric acid secretion in dogs with liver disease, portal hypertension and massive ascites.

Authors:  M J Orloff; C W Windsor
Journal:  Ann Surg       Date:  1966-07       Impact factor: 12.969

5.  Blood flow during obstruction to the venous effect of portacaval transposition on hepatic outflow from the canine liver.

Authors:  P R Baker; R Shields
Journal:  Ann Surg       Date:  1974-07       Impact factor: 12.969

6.  A novel canine model of esophageal varices with a balloon dilatation constrictor.

Authors:  He-Ping Fang; Mei-Hai Deng; Nan Lin; Wei-Dong Pan; Bo Liu; Yun-Biao Lin; Zhao-Feng Tang; Rui-Yun Xu
Journal:  Dig Dis Sci       Date:  2008-10-29       Impact factor: 3.199

7.  Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: experimental and clinical results.

Authors:  M J Orloff; K H Johansen
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.